Ditchcarbon
  • Contact
  1. Organizations
  2. Allergan
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 8 days ago

Allergan

Company website

Allergan, officially known as Allergan plc, is a prominent global pharmaceutical company headquartered in the United States. Founded in 1948, Allergan has established itself as a leader in the biopharmaceutical industry, focusing on areas such as medical aesthetics, eye care, and neuroscience. The company is renowned for its innovative products, including the widely recognised Botox, which has transformed both cosmetic and therapeutic treatments. With major operational regions spanning North America, Europe, and Asia, Allergan has achieved significant milestones, including its acquisition by AbbVie in 2020, further solidifying its market position. The company’s commitment to research and development has led to a diverse portfolio of unique offerings, making it a key player in enhancing patient outcomes and quality of life.

DitchCarbon Score

How does Allergan's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

39

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Allergan's score of 39 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

60%

Let us know if this data was useful to you

Allergan's reported carbon emissions

In 2017, Allergan reported total greenhouse gas emissions of approximately 88,190,000 kg CO2e for Scope 1, 46,800,000 kg CO2e for Scope 2 (market-based), and 250,000,000 kg CO2e for Scope 3 emissions. This data reflects a comprehensive assessment of their carbon footprint, with emissions disclosed across all three scopes. Comparatively, in 2016, Allergan's emissions were about 85,464,000 kg CO2e for Scope 1, 50,279,000 kg CO2e for Scope 2 (market-based), and maintained the same Scope 3 emissions of 250,000,000 kg CO2e. The figures indicate a slight increase in Scope 1 emissions and a decrease in Scope 2 emissions from 2016 to 2017. Allergan's emissions data is cascaded from its parent company, AbbVie Inc., as part of its corporate family relationship. However, there are currently no specific reduction targets or climate pledges documented for Allergan, indicating a potential area for future commitment in line with industry standards. Overall, Allergan's emissions profile highlights the importance of ongoing monitoring and potential strategies for emissions reduction, particularly in Scope 3, which constitutes the majority of their carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2005201020112012201520162017
Scope 1
-
-
-
-
00,000,000
00,000,000
00,000,000
Scope 2
-
-
-
-
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Allergan's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Allergan is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Allergan is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Fresenius Medical Care Holdings, Inc.

US
•
Health and social work services (85)
Updated 11 days ago

Luye Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Lundbeck

DK
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy